Reduction of mutant huntingtin in oligodendroglia rescues myelination and behavioural deficits in a model of Huntington disease

被引:0
|
作者
Bardile, C. F. [1 ]
Garcia-Miralles, M. [1 ]
Caron, N. [1 ]
Teo, R. [1 ]
Hayden, M. R. [1 ,2 ,3 ]
Pouladi, M. A. [1 ,3 ]
机构
[1] Translat Lab Genet Med, Immunos, Singapore, Singapore
[2] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
WTH07-14
引用
收藏
页码:218 / 218
页数:1
相关论文
共 50 条
  • [31] Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model
    Wang, WF
    Duan, WZ
    Igarashi, S
    Morita, H
    Nakamura, M
    Ross, CA
    NEUROBIOLOGY OF DISEASE, 2005, 20 (02) : 500 - 508
  • [32] Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model
    Marchionini, Deanna M.
    Liu, Jeh-Ping
    Ambesi-Impiombato, Alberto
    Kerker, Kimberly
    Cirillo, Kim
    Bansal, Mukesh
    Mushlin, Rich
    Brunner, Daniela
    Ramboz, Sylvie
    Kwan, Mei
    Kuhlbrodt, Kirsten
    Tillack, Karsten
    Peters, Finn
    Rauhala, Leena
    Obenauer, John
    Greene, Jonathan R.
    Hartl, Christopher
    Khetarpal, Vinod
    Lager, Brenda
    Rosinski, Jim
    Aaronson, Jeff
    Alam, Morshed
    Signer, Ethan
    Munoz-Sanjuan, Ignacio
    Howland, David
    Zeitlin, Scott O.
    JCI INSIGHT, 2022, 7 (20)
  • [33] Adeno-Associated Virus Mediated Delivery of Mutant Huntingtin in Mice and Primates to Model Huntington Disease
    Maxan, A.
    Sciacca, G.
    Breger, L.
    Dehay, B.
    Tao, Zhu
    Ling, Zhang
    Qin, Chuan
    Oueslati, A.
    Bezard, E.
    Cicchetti, F.
    NEUROTHERAPEUTICS, 2018, 15 (04) : 1187 - 1188
  • [34] Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease
    Van Raamsdonk, JM
    Murphy, Z
    Slow, EJ
    Leavitt, BR
    Hayden, MR
    HUMAN MOLECULAR GENETICS, 2005, 14 (24) : 3823 - 3835
  • [35] Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease
    Chaudhary, Rajeev K.
    Patel, Kinjal A.
    Patel, Milan K.
    Joshi, Radha H.
    Roy, Ipsita
    MOLECULAR THERAPY, 2015, 23 (12) : 1912 - 1926
  • [36] Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease
    Osmand, Alexander P.
    Bichell, Terry Jo.
    Bowman, Aaron B.
    Bates, Gillian P.
    JOURNAL OF HUNTINGTONS DISEASE, 2016, 5 (04) : 343 - 346
  • [37] Analysis of mutant and total huntingtin expression in Huntington's disease murine models
    Fodale, Valentina
    Pintauro, Roberta
    Daldin, Manuel
    Altobelli, Roberta
    Spiezia, Maria Carolina
    Bisbocci, Monica
    Macdonald, Douglas
    Bresciani, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Allele-Specific Silencing of Mutant Huntingtin for Huntington's Disease Therapy
    Mas-Monteys, Alex
    Harper, Scott Q.
    Gilmore, Brian L.
    Staber, Patrick D.
    Schaffer, Chris
    Polisky, Barry
    Vargeese, Chandra
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S274 - S275
  • [39] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Weiss, Andreas
    Traeger, Ulrike
    Wild, Edward J.
    Grueninger, Stephan
    Farmer, Ruth
    Landles, Christian
    Scahil, Rachael I.
    Lahiri, Nayana
    Haider, Salman
    Macdonald, Douglas
    Frost, Chris
    Bates, Gillian P.
    Bilbe, Graeme
    Kuhn, Rainer
    Andre, Ralph
    Tabrizi, Sarah J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10): : 3731 - 3736
  • [40] Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
    Wild, E. J.
    Weiss, A.
    Trager, U.
    Grueninger, S.
    Farmer, R.
    Landles, C.
    Scahill, R.
    Lahiri, N.
    Haider, S.
    Macdonald, D.
    Frost, C.
    Bates, G.
    Bilbe, G.
    Kuhn, R.
    Andre, R.
    Tabrizi, S.
    MOVEMENT DISORDERS, 2013, 28 : S268 - S269